BPH: Why Do Patients Fail Medical Therapy?

Zeynep G. Gul, Steven A. Kaplan

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Purpose of Review: In this article, we review why patients may fail medical therapy for benign prostatic hyperplasia (BPH) and by doing so, gain a better understanding of the disease process and how to optimize the care of these patients. Recent Findings: A growing body of literature has attempted to better characterize the various mechanisms by which patients develop BPH as well as identify predictors of disease progression and treatment failure. Summary: BPH is a heterogenous disease process. A more personalized approach to treatment, including patient selection for medical or surgical management, would allow us to optimize patient care.

Original languageEnglish
Article number40
JournalCurrent urology reports
Volume20
Issue number7
DOIs
StatePublished - Jul 1 2019

Keywords

  • 5alpha-reductase inhibitors
  • Alpha-blockers
  • Benign prostatic hyperplasia
  • Clinical trial results
  • Medical therapy
  • Predictors of treatment failure

Fingerprint

Dive into the research topics of 'BPH: Why Do Patients Fail Medical Therapy?'. Together they form a unique fingerprint.

Cite this